Literature DB >> 22265377

New and emerging analytical techniques for marine biotechnology.

J Grant Burgess1.   

Abstract

Marine biotechnology is the industrial, medical or environmental application of biological resources from the sea. Since the marine environment is the most biologically and chemically diverse habitat on the planet, marine biotechnology has, in recent years delivered a growing number of major therapeutic products, industrial and environmental applications and analytical tools. These range from the use of a snail toxin to develop a pain control drug, metabolites from a sea squirt to develop an anti-cancer therapeutic, and marine enzymes to remove bacterial biofilms. In addition, well known and broadly used analytical techniques are derived from marine molecules or enzymes, including green fluorescence protein gene tagging methods and heat resistant polymerases used in the polymerase chain reaction. Advances in bacterial identification, metabolic profiling and physical handling of cells are being revolutionised by techniques such as mass spectrometric analysis of bacterial proteins. Advances in instrumentation and a combination of these physical advances with progress in proteomics and bioinformatics are accelerating our ability to harness biology for commercial gain. Single cell Raman spectroscopy and microfluidics are two emerging techniques which are also discussed elsewhere in this issue. In this review, we provide a brief survey and update of the most powerful and rapidly growing analytical techniques as used in marine biotechnology, together with some promising examples of less well known earlier stage methods which may make a bigger impact in the future.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22265377     DOI: 10.1016/j.copbio.2011.12.007

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  8 in total

1.  Bioactive marine drugs and marine biomaterials for brain diseases.

Authors:  Clara Grosso; Patrícia Valentão; Federico Ferreres; Paula B Andrade
Journal:  Mar Drugs       Date:  2014-05-02       Impact factor: 5.118

2.  Stellettin B Induces G1 Arrest, Apoptosis and Autophagy in Human Non-small Cell Lung Cancer A549 Cells via Blocking PI3K/Akt/mTOR Pathway.

Authors:  Ran Wang; Qian Zhang; Xin Peng; Chang Zhou; Yuxu Zhong; Xi Chen; Yuling Qiu; Meihua Jin; Min Gong; Dexin Kong
Journal:  Sci Rep       Date:  2016-05-31       Impact factor: 4.379

Review 3.  Marine-Derived Pharmaceuticals - Challenges and Opportunities.

Authors:  Ulrike Lindequist
Journal:  Biomol Ther (Seoul)       Date:  2016-11-01       Impact factor: 4.634

Review 4.  Marine Bacterial Secondary Metabolites: A Treasure House for Structurally Unique and Effective Antimicrobial Compounds.

Authors:  Ramanathan Srinivasan; Arunachalam Kannappan; Chunlei Shi; Xiangmin Lin
Journal:  Mar Drugs       Date:  2021-09-23       Impact factor: 5.118

5.  Differential in gel electrophoresis (DIGE) comparative proteomic analysis of macrophages cell cultures in response to perthamide C treatment.

Authors:  Annalisa Vilasi; Maria Chiara Monti; Alessandra Tosco; Simona De Marino; Luigi Margarucci; Raffaele Riccio; Agostino Casapullo
Journal:  Mar Drugs       Date:  2013-04-17       Impact factor: 5.118

Review 6.  Therapeutic Properties and Biological Benefits of Marine-Derived Anticancer Peptides.

Authors:  Hee Kyoung Kang; Moon-Chang Choi; Chang Ho Seo; Yoonkyung Park
Journal:  Int J Mol Sci       Date:  2018-03-20       Impact factor: 5.923

Review 7.  Marine-derived protein kinase inhibitors for neuroinflammatory diseases.

Authors:  Chong Ning; Hui-Min David Wang; Rong Gao; Yu-Chia Chang; Fengqing Hu; Xianjun Meng; Shi-Ying Huang
Journal:  Biomed Eng Online       Date:  2018-04-24       Impact factor: 2.819

8.  Explorations on the ecological role of toxin secretion and delivery in jawless predatory Polychaeta.

Authors:  N Cuevas; M Martins; A P Rodrigo; C Martins; P M Costa
Journal:  Sci Rep       Date:  2018-05-16       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.